| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2879709 | The Annals of Thoracic Surgery | 2008 | 9 Pages |
Abstract
“Real world” utilization of the TAG device includes high rates of off-label use (nearly 50%) and “hybrid” techniques (20%) for the treatment of multiple pathologic entities of the thoracic and thoracoabdominal aorta. Regardless, short to mid-term results appear promising. Longer follow-up is needed to determine the durability of this approach.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
G. Chad MD, Mani A. MD, Madhav MD, Jeffrey J. MD, Errol L. MD, Aatif H. MD, Walter G. MD, Richard L. MD,